Ying Tang

Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China

Xiaohua Wu, Yang Sun, Hongying Yang et al. · The Lancet · 2024 · 73 citations

Metastatic Cervical Cancer, Cervical Cancer, Placebo-controlled Phase 3 +9

Human umbilical cord blood-derived mononuclear cell transplantation: case series of 30 subjects with Hereditary Ataxia

Wanzhang Yang, Yun Zhang, Fang Wu et al. · Journal of Translational Medicine · 2011 · 25 citations · Full text

Combined Preoperative LMR and CA125 for Prognostic Assessment of Ovarian Cancer

Ying Tang, Huiquan Hu, Fang-xiang Tang et al. · Journal of Cancer · 2020 · 24 citations · Full text

Serum <scp>CA125</scp> as a biomarker for dysmenorrhea in adenomyosis

Ying Tang, Ming‐bo Wen, Rumei Xiang et al. · International Journal of Gynecology & Obstetrics · 2023 · 19 citations

Preoperative LMR and Serum CA125 Level as Risk Factors for Advanced Stage of Ovarian Cancer

Ying Tang, Huiquan Hu, Ya-lan Tang et al. · Journal of Cancer · 2021 · 14 citations · Full text